PhD Program in Arterial Hypertension and Vascular Biology ARHYVAB

The PhD program in Arterial Hypertension and Vascular Biology is based in the Department of Medicine – DIMED of the University of Padua. This is a referral centre for Arterial Hypertension and cardiovascular diseases in Italy and a Centre of Excellence for Hypertension Research of the European Society of Hypertension (ESH). https://www.unipd.it/dottoratoscheda/arhyvab. https://www.unipd.it/en/phd

This programme is the first in Europe devoted to Hypertension research and was established in conjunction with the University of Rome La Sapienza, Italy. https://phd.uniroma1.it/web/ARTERIAL-HYPERTENSION-AND-VASCULAR-BIOLOGY_nD3561_IT.aspx

To apply for the XLI Cycle to the PhD program in Arterial Hypertension and Vascular Biology, please follow this link: https://www.uniroma1.it/it/pagina/ammissione-ai-corsi-di-dottorato. For English version: https://www.uniroma1.it/en/pagina/admissions-2025-2026-phd-programmes

Course Objective

The PhD Course Arterial Hypertension and Vascular Biology (ARHYVAB) aims to train:
a) researchers with solid expertise in the field of arterial hypertension and its complications, capable of pursuing academic careers in Italy and abroad;
b) clinical researchers who may find employment in academia and in the pharmaceutical industry, with roles in the planning, organization, and conduct of clinical trials on arterial hypertension, as well as in the dissemination of results to the scientific community through dedicated publications.
Specific Objectives of the Course:
1. To provide the skills required to plan, conduct, and analyze clinical and experimental research in both basic and applied science in the fields of arterial hypertension and vascular biology, and more broadly in aging and cardio-cerebrovascular diseases.
2. To train researchers in the areas of genetics, molecular biology, and pharmacogenomics of arterial hypertension, a research field that requires the integration of efforts and resources at the European level.
3. To develop expertise in cardiovascular pharmacology, both in academia and in the pharmaceutical and biotech industries, enabling graduates to join research groups focused on the development of innovative drugs.
4. To promote the skills necessary to design and conduct clinical trials in the field of arterial hypertension.

Professional Profile

Graduates of the PhD Course Arterial Hypertension and Vascular Biology (ARHYVAB) develop a highly qualified professional profile applicable to academic, healthcare, and industrial settings. The program prepares researchers for academic careers as faculty members and investigators at Italian and international universities, as well as for postdoctoral positions and research contracts aimed at pursuing long-term academic trajectories.
The training also enables employment within highly specialized hospital institutions, including positions as medical consultants or senior professionals in clinical diagnostic laboratories. Advanced expertise in vascular biology, cardiovascular pharmacology, and translational research further supports career opportunities in the biotechnology and pharmaceutical industries, encompassing roles in research and development, application science, clinical trial monitoring, and participation in biotech start-ups or entrepreneurial initiatives.
Professional placement in both academic and industrial sectors is strengthened not only by disease-specific knowledge in hypertension and cardiovascular disorders, but also by the rigorous research methodology, project planning skills, and analytical competencies acquired during the ARHYVAB PhD program. These skills have proven to be key determinants for successful careers in research across diverse scientific and professional environments.

  AHRYVAB Phd Course and Curriculum

The PhD entails specific commitment and training in the following areas:

1. Experimental research

  • Vascular biology with emphasis on the endothelium and endothelial (dys)function, and its role in the control of vascular tone;
  • Salt and water homeostasis;
  • Pathophysiology of control of blood pressure;
  • Molecular analysis methodologies;
  • Experimental atherosclerosis;
  • Arterial hypertension from animal models;
  • Molecular and experimental pharmacology;
  • Pharmacokinetics and pharmacodynamics of anti-hypertensive medications.

2. Clinical research

  • Epidemiology and statistics applied to hypertension;
  • Principles of pharmaco-economics applied to hypertension;
  • Methodologies for assessment of target organ damage in hypertension;
  • Pathophysiology of the secondary forms of hypertension;
  • Guidelines for risk stratification and treatment;
  • Design and planning of clinical trials in hypertension.

The First Year of Research

The student will do coursework and labwork.

The curriculum will involve:

  1. General research methods training. An introductory course is held every year at the Venetian Institute of Medicine (VIMM) by the Faculty members of all PhD Courses of the University of Padua and outside experts in scientific fields. The course is focused on ‘How to do research” and covers applications of chemistry and physics to Medicine, genetics, molecular biology, statistics, ethics and social aspects.
  2. Attendance at research workshops and seminars held by the Faculty members and PhD students or outside speakers, mostly focussed on the cardiovascular system.
  3. Advanced coursework in the laboratories. The PhD student has the chance to be educated at a variety of techniques and introduced to a wide array of inter-disciplinary and comprehensive cardiovascular disease programs.

At the end of the 1st year the PhD student is expected to have practised skills of organizing, structuring, and presenting research, hence, he/she will be assigned to a specific research project in the field of Arterial Hypertension and Vascular biology under the strict supervision of an experienced tutor. Whether 1st year PhD student is upgraded to PhD status at the end of the first year of research will depend on his/her performance in the curriculum.

Second and Third Year of Research

Once upgraded to the 2nd year PhD student status, the student will concentrate on his/her PhD labwork to prepare his/her final dissertation. As research progresses, there will be opportunities to present work in progress at research workshops attended by Faculty members and research students. The PhD student will have also the opportunity to attend Journal Club and the Weekly Meetings given by outside speakers and Faculty members.

At the 2nd or the 3rd year the PhD student will spend at least 6 months abroad, at research organisations and universities collaborating with the PhD course.

The normal deadline for submission of the dissertation will be the end of December in the third year of research. Within this time, an original work focussed on the assigned theme should have been completed and discussed in detail with the tutor. The defence will occur about 2 months after, at the presence of the Faculty members.

  Coordinator, Faculty Staff and PhD students

Coordinator

Teresa M. Seccia, University of Padua, I

Faculty Staff

https://cvcollegiodocenti.ict.unipd.it/it/DOT1319972

Giovanna Albertin, University of Padua, I 

Brasilina Caroccia, University of Padua, I

Silvia Ceccanti, University of Rome La Sapienza, I

Giulio Ceolotto, University of Padua, I

Cristina Chimenti, University of Rome La Sapienza, I

Andrea Cignarella, University of Padua, I 

Denis A. Cozzi, University of Rome La Sapienza, I

Filippo Crimì, University of Padua, I

Giancarlo D'ambrosio, University of Rome La Sapienza, I

Carolina De Ciuceis, University of Brescia, I

Franco Grego, University of Padua, I

Maurizio Iacobone, University of Padua, I

Livia Lenzini, University of Padua, I

Claudio Letizia, University of Rome La Sapienza, I 

Stefano Masi, University of Pisa, I

Mirko Menegolo, University of Padua, I

Gianluca Mennini, University of Rome La Sapienza, I

Selenia Miglietta, University of Rome La Sapienza, I

Raffaella Motta, University of Padua, I

Maria Lorenza Muiesan, University of Brescia, I

Elena Pacella, University of Rome La Sapienza, I

Andrea Padoan, University of Padua, I

Luigi Petramala, University of Rome La Sapienza, I

Stefano Piaserico, University of Padua, I

Gianfranco Piccirillo, University of Rome La Sapienza, I

Giacomo Pucci, University of Perugia, I

Marcello Rattazzi, University of Padua, I 

Michela Relucenti, University of Rome La Sapienza, I

Massimo Rossi, University of Rome La Sapienza, I

Giacomo Rossitto, University of Padua, I

Massino Salvetti, University of Brescia, I

Giuliano Tocci, University of Rome La Sapienza, I

Danilo Toni, University of Rome La Sapienza, I

Matthias Barton, University of Zurich, CH

Ariela Benigni, Istituto Mario Negri, I

Ana Briones Alonso, Universidad Autonoma de Madrid, E

Jan Danser, EUR Erasmus University Rotterdam, NL

Christian Delles, University of Glasgow, UK

Tilman Hackeng, CARIM, NL

Jordi Hejman, University of Graz, A

Abraham Kroon, CARIM, NL

Francesca Mallamaci, CNR, I

Marko Poglitsch, Attoquant Diagnostics, A

Koen Reesink, Maastricht University, NL

Gian Paolo Rossi, Forica, I

Casper Schalkwijk, Maastricht University, NL

Leon Schurgers, CARIM, NL

Ulrike Muscha Steckelings, Syddansk Universitet, DN

Maria Christina Zennaro, INSERM, F

 

PhD Students

Cycle XXVIII

Gioco Francesca
Guerzoni Eugenia
Pengo Martino

Cycle XXIX

Citton Marilina
Ravarotto Verdiana
Vanderriele Paul Emmanuel
Viel Giovanni

Cycle XXXII

Scarpa Riccardo
Bisogni Valeria
Prisco Selene
Citoni Barbara
Torresan Francesca
Piazza Maria
Saracino Vincenza

Cycle XXXIII

Calvez Valentin
Cesario Vincenzo
Concistrè Antonio
Crimì Filippo
Miceli Francesca
Zingaretti Viviana

Cycle XXXIV

Caputo Ilaria
Nicolini Ettore
Presta Vivianne
Schiavone Donatella
Shagjaa Tungalagtamir
Zhu RUI

Cycle XXXV

Adducci Carmen
Alfarano Maria
Bressan Alessandro
Duraku Muja Eva
Figliuzzi Ilaria
Letteri Federica
Pata Francesco
Risitano Angela
Sanga Viola
Spimpolo Alessandro
Tartaglione Lida

Cycle XXXVI

Ajjour Hala
Byiringiro Clement
Circosta Francesco
Giovanardi Francesco
Mariani Marco Valerio
Neccia Matteo
Petraglia Luca
Tini Melato Giacomo

Cycle XXXVII

Bagordo Domenico
Kohlscheen Eva
Pintus Giovanni
Zanon Chiara

Cycle XXXVIII

Bertoli Eleonora
Cabrelle Giulio
Costanzo Maria Ludovica
Scoccia Gianmarco
Zanella Luca

Cycle XXXIX

Catalfamo Marta
Khatoon Narjis
Mustafa Atta Ul
Poretto Anna
Rossi Federico

Cycle XL

Agostini Elena
Costantino Jacopo
D'alessandro Carlo
Marchionni Giulia
Myftari Vincenzo
Rizzo Massimiliano
Sammarco Ambra
Talli Ilaria
Tomarelli Elisa

Cycle XLI

Amisano Paolo
Barbon Tommaso
Cappelli Federica
Ciuffreda Antonella
Melloni Martina

  Classrooms

From Golgi to modern Neuroscience. Celebration
21/01/2026 ore 09.30
Accademia Nazionale dei Lincei - Palazzo Corsini - Roma

The imitation game: adattamento cellulare e resistenza nel carcinoma del pancreas
21/01/2026 ore 17.00
Accademia Medica di Roma

Corso di scrittura tecnico-scientifica
10-19 Febbraio 2026
Facoltà di Ingegneria - Roma

Lesioni a rischio, precancerose e tumori dello stomaco: malattie multifattoriali e trascurate
11/02/2026 ore 17.00
Accademia Medica di Roma

Immune surveillance of the liver
04/03/2026 ore 17.00
Accademia Medica di Roma

Omeostasi proteica e neurodegenerazione: meccanismi molecolari e prospettive terapeutiche
11/03/2026 ore 17.00
Accademia Medica di Roma

Un gioco di segnali lipidici per orchestrare i processi infiammatori
18/03/2026 ore 17.00
Accademia Medica di Roma

Autoinfiammazione: dalle febbri ricorrenti monogeniche alla malattia di Still
25/03/2026 ore 17.00
Accademia Medica di Roma

Spazio e tempo nella risposta dei linfociti T della memoria: implicazioni in fisiologia e patologia
01/04/2026 ore 17.00
Accademia Medica di Roma

Medicina di Precisione: Verso una Sanità Personalizzata ed Efficiente
Genomi in corsia: la rivoluzione della medicina personalizzata
Il diabete mellito: uno, nessuno, centomila?
Organoidi come Modelli Pre-clinici: Un ponte verso la Medicina Personalizzata
Dalle cellule staminali del cancro ai modelli tumorali su chip: implicazioni terapeutiche
08/04/2026 ore 17.00
Accademia Medica di Roma

Trapianto di organi: da dove siamo partiti e dove vorremmo (forse) arrivare
29/04/2026 ore 17.00
Accademia Medica di Roma

Methodologies for Histological and Cytological Data: From Sampling to laboratory Research
Prof.Giovanna Albertin
Aula/Room Sterzi - Istituto di Anatomia

03/03/2026 - h. 16.00 - 17.30
10/03/2026 - h. 16.00 - 17.30
17/03/2026 - h. 16.00 - 17.30

Clinical Genetics
Prof. Eva Trevisson
Aula/Room Radiologia – P. Terra Policlinico

23/03/2026 14.30 - 16.30
30/03/2026 14.30 - 16.30
13/04/2026 14.30 - 16.30

Medicina di laboratorio avanzata: approcci clinici e sperimentali (mutuato)
Dr. Ada Aita, Dr Paola Galozzi
Aula/Room Castellino - P. Terra Policlinico

28/01/2026 15.30 - 17.30
04/02/2026 15.30 - 17.30
11/02/2026 15.30 - 17.30
18/02/2026 15.30 - 17.30
04/03/2026 15.30 - 17.30
11/03/2026 15.30 - 17.30

Scientific Communication, Open Science and the Institutional Archives
Dr: Valentina Bozzato, Dr. Federico Fogo, Dr. Antonia Vilia
Aula/Room Radiologia – P. Terra Policlinico

17/06/2026 16.00 - 17.30
24/06/2026 16.00 - 17.30
01/07/2026 16.00 - 17.30

Biostatistics month
Prof. D. Gregori
Date and place to be confirmed

  Past Classrooms

HFNC
Prof. Petramala
29/01/2025

Emorragie/anemia da perdita acuta: gestione medica emorragie massive
Prof.ssa Clementi
05/02/2025

NIV in urgenza
Dott. Colantonio
19/02/2025

Sindrome da carcinoide
Dott. Palombi
26/02/2025

Sindrome di Steven Jhonson
19/03/2025

2025 Winter School in Cardiovascular Medicine
PhD Program Arterial Hypertension and Vascular Biology (ARHYVAB). University of Padua.
24-28 Marzo 2025 - Bolzano

La doppia defibrillazione sequenziale
02/04/2025

Sindrome da botulino
Prof. Suppa
09/04/2025

Fibrillazione atriale: dai sintomi alla gestione del paziente
Prof. Coppola
07/05/2025

Un caso di ipercalcemia
Dott.ssa Di Bona
14/05/2025

La terapia anticoagulante nel paziente complesso
Prof. D. Pastori
28/05/2025

La malaria in PS
04/06/2025

Correggere il DNA per curare le malattie genetiche del cuore
08/06/2025 ore 11.00
Accademia Nazionale dei Lincei - Palazzo Corsini - Roma
Info: https://www.lincei.it/it/manifestazioni/lettura-corsiniana-correggere-il-dna

Epilepsies in children, young people and adults
18/06/2025

BRASH syndrome
25/06/2025

Giornate romane dell'ipertensione
03-04 Luglio 2025
Hotel The Hive - Roma

Un caso di FUO
09/07/2025

VII convegno DIMED "from bench to bedside"
11/11/2025
Centro Culturale Altinate San Gaetano - Padova

Cellule CAR T, dalle applicazioni consolidate alle sfide future
17/11/2025 ore 17.00
Accademia Medica di Roma

Congresso SIIA Triveneto: Aggiornamenti in tema d’ipertensione arteriosa
29/11/2025
Istituto Teologico Sant'Antonio Dottore - Padova

Atrofia muscolare spinale e nuove terapie: al meglio non c'è mai fine
03/12/2025 ore 17.00
Accademia Medica di Roma

Next-Gen 3D and spatial imaging for Biomedical Discovery
16/12/2025 ore 14.30
Polo Scientifico Vallisneri - Padova

I nuovi farmaci ipoglicemizzanti
17/12/2025 ore 17.00
Link Zoom: https://us02web.zoom.us/j/84252642087

  Recent Publications

Variability Between Radiation-Induced Cancer Risk Models in Estimating Oncogenic Risk in Intensive Care Unit Patients. Quaia E, Zanon C, Torchio R, Dughiero F, De Monte F, Paiusco M. Tomography. 2025 Apr 3;11(4):42. doi: 10.3390/tomography11040042. PMID: 40278709; PMCID: PMC12030842.v

Subtyping of Primary Aldosteronism by Adrenal Venous Sampling. Rossi, G. P., Battistel, M., Seccia, T. M., Rossi, F. B., & Rossitto, G. (2025). Endocrine Reviews. DOI: 10.1210/endrev/bnaf007/8020816
 
Rethinking arterial hypertension: the need for a paradigm shift. Rossi, G. P., Bagordo, D., & Rossi, F. B. (2025). Curr Opin Nephrol Hypertens, 34, 000–000. DOI: 10.1097/MNH.0000000000001065

Epicardial fat volume and tissue characterization in patients with primary aldosteronism. Rossitto G; Bagordo D; Lupi A; Cabrelle G; Crimì, F; Quaia E; Pepe A. Journal of Hypertension 43(Suppl 1):p e156, May 2025.

Dissecting the contributions of composition and mesostructure on the release of thymol from silica-based mesopowders. B E., Stocco, M., Barbon, T., Rancan, M., Martucci, A., & Morpurgo, M. (2025). Journal of Drug Delivery Science and Technology, 110, 107066. https://doi.org/10.1016/J.JDDST.2025.107066

The impact of dominant ventricle morphology and additional ventricular chamber size on clinical outcomes in patients with Fontan circulation. Padalino MA, Ponzoni M, Reffo E, Azzolina D, Cavaliere A, Puricelli F, Cabrelle G, Bergonzoni E, Cao I, Gozzi A, Castaldi B, Vida V, Di Salvo G. Cardiol Young. 2025 Jan;35(1):126-135.

How Blood Pressure Tracks - Salty and Secondary Causes. Rossi, F. B., Cabrelle, G., & Rossitto, G. (2025). JAMA Pediatrics. DOI: 10.1001/jamapediatrics.2025.0048

Krebs von den Lungen-6 (KL-6): le nostre evidenze in fibrosi polmonare da COVID-19 e asma grave. Cosma C, Molena B, Talli I, Pangrazzi E, Marchioro L, Padoan A, et al. Biochim Clin 2025 Nov 04. DOI: 10.23736/S0393-0564.25.00058-5.

Determinazione della progranulina con un nuovo metodo automatizzato. Pangrazzi E, Cosma C, Talli I, Padoan A, Zaninotto M, Cerutti H, et al. Biochim Clin 2025;49:344-9. DOI: 10.23736/S0393-0564.25.00037-8.

Impact of analytical bias on machine learning models for sepsis prediction using laboratory data. Yesil MR, Talli I, Pelloso M, Cosma C, Pangrazzi E, Plebani M, Ustundag Y, Padoan A. Clin Chem Lab Med. 2025 May 28. doi: 10.1515/cclm-2025-0491. Epub ahead of print. PMID:40440484. 

A machine learning approach for assessing acute infection by erythrocyte sedimentation rate (ESR) kinetics. Padoan A, Talli I, Pelloso M, Galla L, Tosato F, Diamanti D, Cosma C, Pangrazzi E, Brogi A, Zaninotto M, Plebani M. Clin Chim Acta. 2025:120308. doi:10.1016/j.cca.2025.120308. PMID: 40274178

Measurement of AST and ALT with Pyridoxal-5'-Phosphate according to IFCC: A decades-long gap seems to be filled. Talli I, Marchioro L, Zaninotto M, Cosma C, Pangrazzi E, Artusi C, Padoan A, Plebani M. Clin Chim Acta. 2025 Jan 30;569:120158. doi: 10.1016/j.cca.2025.120158. Epub ahead of print. PMID: 39892693.

Progranulin measurement with a new automated method: a step forward in the diagnostic approach to neurodegenerative disorders. Cosma C, Talli I, Pangrazzi E, Padoan A, Cerutti H, Zaninotto M, Gabelli C, Plebani M. Clin Chem Lab Med. 2025 Jan 20. doi: 10.1515/cclm-2024-1143. Epub ahead of print. PMID: 39819746. 

Mucosal mediators of patients with diverticular disease increase Caco-2 cell permeability: results from an in vitro study. Poster. Melloni M. IV Congresso Nazionale SINGEM 2025.

Characterization of neuronal markers expression in esophageal mucosa of achalasia patients. Poster. Melloni M. IV Congresso Nazionale SINGEM 2025.

The role of ribosomal proteins and MYC interplay in osteosarcoma: Investigating new candidate prognostic biomarkers. Poster. Melloni M. VII Congresso Nazionale I.S.O. E.T.S. 2024.

Could CT Radiomic Analysis of Benign Adrenal Incidentalomas Suggest the Need for Further Endocrinological Evaluation? Toniolo, A.; Agostini, E.; Ceccato, F.; Tizianel, I.; Cabrelle, G.; Lupi, A.; Pepe, A.; Campi, C.; Quaia, E.; Crimì, F. Curr. Oncol. 2024, 31, 4917–4926

Role of Lugol solution before total thyroidectomy for Graves' disease: randomized clinical trial. Schiavone D, Crimì F, Cabrelle G, Pennelli G, Sacchi D, Mian C, Torresan F, Iacobone M. Br J Surg. 2024 Aug 2;111(8):znae196.

Introduction to Special Issue Imaging in Cancer Diagnosis. Zanon C, Quaia E, Crimì F. Tomography. 2024 Jan 15;10(1):101-104. doi: 10.3390/tomography10010009. PMID: 38250955; PMCID: PMC10820471.

Radiation Overuse in Intensive Care Units. Zanon C, Bini C, Toniolo A, Benetti T, Quaia E. Tomography. 2024; 10(2):193-202. 

Re: The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study. Cabrelle G, Zanon C, & Rossi, GP (2024). Hypertension research: official journal of the Japanese Society of Hypertension, 47(6), 1750–1751. 

Potential Benefits of Photon-Counting CT in Dental Imaging: A Narrative Review. Zanon C, Pepe A, Cademartiri F, Bini C, Maffei E, Quaia E, Stellini E, & Di Fiore A. (2024). Journal of clinical medicine, 13(8), 2436. https://doi.org/10.3390/jcm13082436

Computed Tomography Effective Dose and Image Quality in Deep Learning Image Reconstruction in Intensive Care Patients Compared to Iterative Algorithms. Quaia E, Kiyomi Lanza de Cristoforis E, Agostini E, & Zanon C. (2024). Tomography (Ann Arbor, Mich.), 10(6), 912–921. https://doi.org/10.3390/tomography10060069

The Interplay Between the MYC Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic Targets. Guerrieri AN, Hattinger CM, Marchesini F, Melloni M, Serra M, Ibrahim T, Penzo M. Int. J. Mol. Sci. 2024, 25(22), 12031; doi.org/10.3390/ijms252212031

Publishing in open access journals. Quaia E, Zanon C, Vieira A, Loewe C, Marti-Bonmatí L. Insights Imaging. 2024 Aug 26;15(1):212. doi: 10.1186/s13244-024-01794-6. PMID: 39186113; PMCID: PMC11347506.

A Machine Learning Model Based on MRI Radiomics to Predict Response to Chemoradiation Among Patients with Rectal Cancer. Crimì F, D'Alessandro C, Zanon C, Celotto F, Salvatore C, Interlenghi M, Castiglioni I, Quaia E, Pucciarelli S, Spolverato G. Life (Basel). 2024 Nov 22;14(12):1530. doi: 10.3390/life14121530. PMID: 39768239; PMCID: PMC11677041.

Revealing Aortic Health: A Radiomic Approach for Early Acute Aortic Syndrome Detection on Non-Contrast Computed Tomography. Zanon C, Toniolo A, Spertino A, Bini C, Cabrelle G, Antonello M, Quaia E, Pepe A. Atherosclerosis 2024, 395, 118118, doi:10.1016/j.atherosclerosis.2024.118118.

Correlation between thoracic aortic diameters and cardiovascular risk factors by computed tomography angiography. Zanon C, Sebastiano G, Barbato L, Bini C, Mochen M, Macrì Demartino R, Cabrelle G, Quaia E, Pepe A. Atherosclerosis, Volume 395, Supplement 1, 2024, 118123, ISSN 0021-9150, https://doi.org/10.1016/j.atherosclerosis.2024.118123.

Advantages of Photon-Counting Detector CT in Aortic Imaging. Zanon C, Cademartiri F, Toniolo A, Bini C, Clemente A, Colacchio EC, Cabrelle G, Mastro F, Antonello M, Quaia E, Pepe A. Tomography 2023, 10 (1), 1–13. https://doi.org/10.3390/tomography10010001.

Imaging minimal residual disease evaluation in multiple myeloma using [18F]FDG PET/MRI. Barilà G, Crimì F, Arangio Febbo M, Pavan L, Vedovato S, Cabrelle G, Zanon C, Campi C, Cecchin D, Zucchetta P, Lacognata C, Semenzato G, Zambello R. Leuk Lymphoma. 2023 Feb;64(2):503-506. doi: 10.1080/10428194.2022.2142053. Epub 2022 Nov 16. PMID: 36382776.

Correlation among semiquantitative High-Resolution Computed Tomography severity scores and clinical and biochemical parameters in COVID-19, is it really effective?. Zanon C, Cabrelle G, Crimì F, Quaia E. Clin Respir J. 2023 Feb;17(2):122-123. doi: 10.1111/crj.13567. Epub 2022 Dec 26. PMID: 36572654; PMCID: PMC9880670.

New Frontiers in Oncological Imaging. Zanon C, Crimì A, Quaia E, Crimì F. Tomography. 2023 Jul 7;9(4):1329-1331. doi: 10.3390/tomography9040105. PMID: 37489473; PMCID: PMC10366894.

CT Texture Analysis of Adrenal Pheochromocytomas: A Pilot Study. Crimì F, Agostini E, Toniolo A, Torresan F, Iacobone M, Tizianel I, Scaroni C, Quaia E, Campi C, Ceccato F.  Current Oncology. 2023; 30(2):2169-2177. https://doi.org/10.3390/curroncol30020167

Medical Radiology: Current Progress. Pepe A, Crimì F, Vernuccio F, Cabrelle G, Lupi A, Zanon C, Gambato S, Perazzolo A, Quaia E. Diagnostics (Basel). 2023 Jul 21;13(14):2439. doi: 10.3390/diagnostics13142439. PMID: 37510183; PMCID: PMC10378672.

Photon-counting Detector CT in Vascular Imaging. Zanon, C.; Cademartiri, F.; Toniolo, A.; Bini, C.; Clemente, A.; Colacchio, E.C.; Cabrelle, G.; Mastro, F.; Antonello, M.; Quaia, E.; Pepe, A.  Preprints 2023, 2023101649. https://doi.org/10.20944/preprints202310.1649.v1

New Trends and Advances in MRI and PET Hybrid Imaging in Diagnostics. Crimì F, Zanon C, Crimì A, Cabrelle G, Quaia E. Diagnostics (Basel). 2023 Sep 13;13(18):2936. doi: 10.3390/diagnostics13182936. PMID: 37761303; PMCID: PMC10528814.

Clinical Management of Primary Aldosteronism: An Update. Rossi, G. P., Rossi, F. B., Guarnieri, C., Rossitto, G., & Seccia, T. M. (2024).  Hypertension, 81, 1845–1856. DOI: 10.1161/HYPERTENSIONAHA.124.22642

Water and Electrolyte Content in Salt-Dependent HYpertension in the SKIn (WHYSKI): Effect of Surgical Cure of Primary Aldosteronism. Torresan, F., Rossi, F. B., Zanin, S., Caputo, I., Caroccia, B., Iacobone, M., & Rossi, G. P. (2024). High Blood Pressure and Cardiovascular Prevention, 31(1). DOI: 10.1007/s40292-023-00614-0

Water and Electrolyte Content in Hypertension in the Skin (WHYSKI) in Primary Aldosteronism. Torresan, F., Rossi, F. B., Caputo, I., Zanin, S., Caroccia, B., Mattarei, A., Paccagnella, M., Kohlscheen, E., Seccia, T. M., Iacobone, M., & Rossi, G.-P. (2024).  Hypertension, 81(12), 2468–2478. DOI: 10.1161/HYPERTENSIONAHA.124.23700
 
‘Essential’ arterial hypertension: time for a paradigm change. Rossi, G. P., Bagordo, D., Rossi, F. B., Pintus, G., Rossitto, G., & Seccia, T. M. (2024).  Journal of Hypertension, 42(1). DOI: 10.1097/hjh.0000000000003767

Evaluation of the Comparability of Wantai Wan200+ Instrument with Routine Laboratory Assays for 21 Different Analytes. Talli I, Padoan A, Cosma C, Furlan G, Zaninotto M, Marchioro L, Galozzi P, Basso D, Plebani, M. J Clin Med. 2024 Apr 12;13(8):2246. doi: 10.3390/jcm13082246. PMID: 38673517; PMCID: PMC11051161. 

Clinical and Analytical Performance of ELISA Salivary Serologic Assay to Detect SARS-CoV-2 IgG in Children and Adults. Padoan A, Cosma C, Di Chiara C, Furlan G, Gastaldo S, Talli I, Donà D, Basso D, Giaquinto C, Plebani M. Antibodies (Basel). 2024 Jan 5;13(1):6. doi:10.3390/antib13010006. PMID: 38247570; PMCID: PMC10801479.

Strategies and considerations in the management of sapheno-femoral and sapheno-popliteal junction thrombosis: a case series. Turatti G, Sammarco A, Boscaro F, Poretto A, Ceccato D, Avruscio G. 2024 XXVIII Congresso Nazionale SISET.

Use of direct oral anticoagulants in catheter-related thrombosis: a single centre experience. Sammarco A, Turatti G, Poretto A, Boscaro F, Ceccato D, Avruscio G. 2024 XXVIII Congresso Nazionale SISET.

Efficacy and safety of therapy with edoxaban in the prevention of venous thromboembolism. Novello S, Sammarco A, Turatti G, Ceccato D, Poretto A, Avruscio G. 2024 XXVIII Congresso Nazionale SISET.

Evaluation of a new molecular test for the detection of SARS-CoV-2 nucleic acid in salivary samples. Talli I, Padoan A, Moz S, Navaglia F, Plebani M, Basso D. J Med Biochem. 2023 Oct 27;42(4):658-664. doi: 10.5937/jomb0-43822. PMID: 38084251; PMCID: PMC10710785. 

Endocrine disruptors and arterial hypertension: A developing story. Caroccia, B., Caputo, I., Rossi, F. B., Piazza, M., Pallafacchina, G., & Paolo Rossi, G. (2023). Steroids, 199. DOI: 10.1016/j.steroids.2023.109292

Analytical and clinical evaluations of SNIBE Maglumi chemiluminescent immunoassay for the detection of SARS-CoV-2 antigen in salivary samples. Padoan A, Talli I, Cosma C, Moz S, Furlan G, Navaglia F, Marchioro L, Zaninotto M, Basso D, Plebani M. Clin Chem Lab Med. 2023 Oct 4. doi: 10.1515/cclm-2023-0947. Epub ahead of print. PMID: 37787733.

Thirty-six-month results of laparoscopic-based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone-producing Adenoma, Letter to the Editor. Schiavone D, Iacobone M, Rossi GP. Journal of Clinical Hypertension - 2022. PMID: 34967112 - DOI: 10.1111/jch.14416

Identification of glucocorticoid-related molecular signature by whole blood methylome analysis. Armignacco R, Anne Jouinot A, Bouys L, Septier A, Lartigue T, Neou M, Gaspar C, Karine Perlemoine K, Braun L, Riester A, Bonnet-Serrano F, Blanchard A, Amar L, Scaroni C, Ceccato F, Rossi GP, Williams TA, Larsen C, Allassonnière S, Zennaro MC, Beuschlein F, Reincke M, Bertherat J, Assié G. European Journal of Endocrinology - 2022. PMID: 34914631 - DOI: 10.1530/EJE-21-0907

Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism. Rossi GP, Crimì F, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LS, Vonend O, Willenberg H, Fuller PJ, Yang J, Yong Nian Chee N, Magill SB, Shafigullina Z, Quinkler M, Oliveras A, Wu VC, Kratka Z, Barbiero G, Battistel M, Seccia TM. Hypertension - 2022. PMID: 34878892 - DOI: 10.1161/HYPERTENSIONAHA.121.18284

Modern Management of Hypertensive Emergencies. Rossi GP, Rossitto G, Maifredini C, Barchitta A, Bettella A, Cerruti L, Latella R, Ruzza L, Sabini B, Vigolo, Seccia TM. High Blood Pressure & Cardiovascular Prevention - 2022. PMID: 34813055 - DOI: 10.1007/s40292-021-00487-1

Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism, Letter to the Editor. Rossi GP, Rossitto G. Journal of Clinical Endocrinology & Metabolism - 2022. PMID: 34610120 - DOI: 10.1210/clinem/dgab717

Neuropeptide G Protein-Coupled Receptor Regulation of Adrenal Function: Bench to Bedside and Back. Lenzini L, Caroccia B, Seccia TM, Rossi GP. Endocrine Reviews - 2022. PMID: 35436330 - DOI: 10.1210/endrev/bnac011 

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells. Caputo I, Caroccia B, Frasson I, Poggio E, Zamberlan S, Morpurgo M, Seccia TM, Calì T, Brini M, Richter SN, Rossi GP. International Journal Of Molecular Sciences - 2022. PMID: 35563515 - DOI: 10.3390/ijms23095125

Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review. Sanga V, Rossitto G, Seccia TM, Rossi GP. Hypertension - 2022. PMID: 35686552 - DOI: 10.1161/HYPERTENSIONAHA.121.18858

Aldosterone and Cardiovascular Damage: a New Lesson From an Old Study. Rossi GP, Rossitto G. Hypertension - 2022. PMID: 35947644 - DOI: 10.1161/HYPERTENSIONAHA.122.19662 

Preanalytical Considerations and Outpatient Versus Inpatient Tests of Plasma Metanephrines to Diagnose Pheochromocytoma. Pommer G, Pamporaki C, Peitzsch M, Remde H, Deutschbein T, Nölting S, Müller LM, Braun L, Gruber S, Pecori A, Hampson S, Davies E, Stell A, Rossi GP, Lenzini L, Ceccato F, Timmers HJLM, Deinum J, Amar L, Blanchard A, Baron S, Fassnacht M, Dobrowolski P, Januszewicz A, Zennaro MC, Prejbisz A, Eisenhofer G. Journal of Clinical Endocrinology & Metabolism - 2022. PMID: 35767279  - DOI: 10.1210/clinem/dgac390

Predicting Hypertension Subtypes with Machine Learning Using Targeted Metabolites and Their Ratios. Reel S, Reel PS, Erlic Z, Amar L, Pecori A, Larsen CK, Tetti M, Pamporaki C, Prehn C, Adamski J, Prejbisz A, Ceccato F, Scaroni C, Kroiss M, Dennedy MC, Deinum J, Eisenhofer G, Langton K, Mulatero P, Reincke M, Rossi GP, Lenzini L, Davies E, Gimenez-Roqueplo AP, Assié G, Blanchard A, Zennaro MC, Beuschlein F, Jefferson ER. Metabolites - 2022. PMID: 36005627 - DOI: 10.3390/metabo1208075 

Identification of risk loci for primary aldosteronism in genome-wide association studies. Le Floch E, Cosentino T, Larsen CK, Beuschlein F, Reincke M, Amar L, Rossi GP, De Sousa K, Baron S, Chantalat S, Saintpierre B, Lenzini L, Frouin A, Giscos-Douriez I, Ferey M, Abdellatif AB, Meatchi T, Empana JP, Jouven X, Gieger C, Waldenberger M, Peters A, Cusi D, Salvi E, Meneton P, Touvier M, Deschasaux M, Druesne-Pecollo N, Boulkroun S, Fernandes-Rosa FL, Deleuze JF, Jeunemaitre X, Zennaro MC. Nature Communications - 2022. PMID: 36057693 - DOI: 10.1038/s41467-022-32896-8

Challenges in the evaluation of endothelial cell dysfunction: a statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors. Rossi GP, Barton M, Dhaunc N, Rizzoni D, Seccia TM.  Journal of Hypertension - 2022 PMID: 36728915 - DOI:10.1097/HJH.0000000000003314

Whole blood methylome-derived features to discriminate endocrine hypertension. Armignacco R, Reel PS, Reel S, Jouinot A, Septier A, Gaspar C, Perlemoine K, Larsen CK, Bouys L, Braun L, Riester A, Kroiss M, Bonnet-Serrano F, Amar L, Blanchard A, Gimenez-Roqueplo AP, Prejbisz A, Januszewicz A, Dobrowolski P, Davies E, MacKenzie SM, Rossi GP, Lenzini L, Ceccato F, Scaroni C, Mulatero P, Williams TA, Pecori A, Monticone S, Beuschlein F, Reincke M, Zennaro MC, Bertherat J, Jefferson E, Assié G. Clinical Epigenetics - 2022. PMID: 36329530 - DOI: 10.1186/s13148-022-01347-y

Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study. Reel PS, Reel S, van Kralingen JC, Langton K, Lang K, Erlic Z, Larsen CK, Amar L, Pamporaki C, Mulatero P, Blanchard A, Kabat M, Robertson S, MacKenzie SM, Taylor AE, Peitzsch M, Ceccato F, Scaroni C, Reincke M, Kroiss M, Dennedy MC, Pecori A, Monticone S, Deinum J, Rossi GP, Lenzini L, McClure JD, Nind T, Riddell A, Stell A, Cole C, Sudano I, Prehn C, Adamski J, Gimenez-Roqueplo AP, Assié G, Arlt W, Beuschlein F, Eisenhofer G, Davies E, Zennaro MC, Jefferson E. Ebiomedicine - 2022. PMID: 36179553 - DOI: 10.1016/j.ebiom.2022.104276

Peptidergic G Protein-Coupled Receptor Regulation of Adrenal Function: Bench to Bedside and Back. Lenzini L, Caroccia B, Seccia TM, Rossi GP. Endocrine Reviews - 2022. PMID: 35436330 - DOI: 10.1210/endrev/bnac011

Serum levels of autoantibodies against the angiotensin II type I receptor are not associated with serum dicarbonyl or AGE levels in patients with an aldosterone-producing adenoma. Piazza M, Hanssen NMJ, Scheijen JLJM, Vd Waarenburg M, Caroccia B, Seccia TM, Stehouwer CDA, Rossi GP, Schalkwijk CG. Journal of Human Hypertension - 2022. PMID: 36418426 - DOI: 10.1038/s41371-022-00773-y 

Skin Hyperpigmentation Due to Post-Surgical Adrenal Insufficiency Regressed with the Dexamethasone Treatment. Shagjaa T, Sanga V, Rossi GP. Journal of Clinical Medicine - 2022. PMID: 36143026 - DOI: 10.3390/jcm11185379

Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic International Study. Rossi GP, Crimì F, Rossitto G, Amar L, Azizi M, Riester A, Reincke M, Degenhart C, Widimsky J, Naruse M, Jaap Deinum J, Schultze Kool L, Kocjan T, Negro A, Rossi E, Kline G, Tanabe A, Satoh F, Rump LC, Vonend O, Willenberg HS, Fuller PJ, Yang J, Yong Nian Chee N, Magill S, Shafigullina Z, Quinkler M, Oliveras A, Cent Wu V, Kratka Z, Barbiero G, Seccia TM, Battistel M. Journal of Clinical Endocrinology & Metabolism - 2021. PMID: 34212188 - DOI: 10.1210/clinem/dgab482       

Comparison of Cortisol, Androstenedione and Metanephrines to Assess Selectivity and Lateralization of Adrenal Vein Sampling in Primary Aldosteronism. Ceolotto G, Antonelli G, Caroccia B, Battistel M, Barbiero G, Plebani M, Rossi GP. Journal of Clinical Medicine - 2021. PMID: 34682878 - DOI: 10.3390/jcm10204755

Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis. Maiolino G, Bisogni V, Soranna D, Pengo M, Pucci G, Vettor R, Fava C, Colussi GL, Bilo G, Lombardi C, Parati G, Rossi GP, Silvani A. Sleep Disorders Working Group of the Italian Society of Hypertension. Sleep Medicine Reviews - 2021. PMID: 34044356 - DOI: 10.1016/j.smrv.2021.101497 

A systematic review of pathophysiology and management of familial hyperaldosteronism type 1 in pregnancy. Sanga V, Seccia TM, Rossi GP. Endocrine - 2021. PMID: 34043182 - DOI: 10.1007/s12020-021-02763-5

Performance of the Aldosterone-to-Renin Ratio as a Screening Test for Primary Aldosteronism: A Systematic Review and Meta-Analysis, Letter to the Editor. Zhu R, Tungalagtamir S, Seccia TM, Rossi GP. Journal of Clinical Endocrinology & Metabolism - 2021. PMID: 34197581 - DOI: 10.1210/clinem/dgab485

Outcome of adrenal vein sampling and computed tomography guided adrenalectomy in primary aldosteronism. Crimì F, Torresan F, Iacobone M, Rossi GP. Journal of Hypertension - 2021. PMID: 34188009 - DOI: 10.1097/HJH.0000000000002882

Management of hypertensive emergencies: a practical approach. Rossi GP, Rossitto G, Maifredini C, Barchitta A, Bettella A, Latella R, Ruzza L, Sabini B, Seccia TM. Blood Pressure - 2021. PMID: 33966560 - DOI: 10.1080/08037051.2021.1917983

Aldosterone and Cortisol Synthesis Regulation by Angiotensin-(1-7) and ACE-2 in The Human Adrenal Cortex. Caroccia B, Vanderriele PE, Seccia TM, Piazza M, Lenzini L, Prisco S, Torresan F, Domenig O, Iacobone M, Poglitsch M, Rossi GP. Journal of Hypertension - 2021. PMID: 33657582 - DOI: 10.1097/HJH.0000000000002816

Reduced adrenal surgery in COVID-19 pandemic: a possible ticking time bomb. Schiavone D, Torresan F, Rossi GP, Iacobone M. British Journal of Surgery - 2021. PMID: 33842946 - DOI:10.1093/bjs/znab098

Ablation versus laparoscopic adrenalectomy for the treatment of aldosterone-producing adenoma: a meta-analysis. Letter to the editor. Schiavone D, Sanga V, Iacobone M, Rossi GP. Abdominal Radiology - 2021. PMID: 33624132 - DOI 10.1007/s00261-021-02995-z

Urinary sodium potassium ratio is associated with clinical success after adrenalectomy in patients with unilateral primary aldosteronism. Zhu R, Seccia TM, Rossi GP. Therapeutic Advances in Chronic Disease - 2021. PMID: 34178299 - DOI: 10.1177/20406223211022650 

The cardiovascular consequences of hyperaldosteronism. Rossi GP, Seccia TM, Maiolino G, Cesari M. Annales d’Endocrinologie - 2021. PMID: 32192789 - DOI: 10.1016/j.ando.2020.02.006.

High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. Rossitto G, Maiolino G, Lerco S, Ceolotto G, Blackburn G, Mary S, Antonelli G, Berton C, Bisogni V, Cesari M, Seccia TM, Lenzini L, Pinato A, Montezano A, Touyz RM, Petrie MC, Daly R, Welsh P, Plebani M, Rossi GP, Delles C. Cardiovascular Research - 2021. PMID: 33053160 - DOI: 10.1093/cvr/cvaa205

Are microcatheters really necessary in adrenal vein sampling (AVS) in primary aldosteronism? Letter to the Editor. Crimi F, Torresan F, Rossi GP. British Journal of Radiology - 2021. PMID: 33684300 - DOI: 10.1259/bjr.20200387

Familial hyperaldosteronism type 1 in pregnancy: a happy end with low dose dexamethasone. Sanga V, Lenzini L, Seccia TM ROSSI GP. Blood Pressure - 2021. PMID: 33390031 - DOI: 10.1080/08037051.2020.1863771

Development and Validation of Criteria for Sparing Confirmatory Tests in Diagnosing Primary Aldosteronism. Letter to the Editor. Zhu R, Rossi GP. Journal of Clinical Endocrinology & Metabolism - 2021. PMID: 33125050 - DOI: 10.1210/clinem/dgaa787 

Functional imaging by 11C-metomidate PET: a really useless technique for primary aldosteronism subtyping? Crimì F, Spimpolo A, Cecchin D, Rossi GP. European Journal of Endocrinology - 2021. PMID: 33555270 - DOI: 10.1530/EJE-20-1402

The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients. Pappaccogli M, Di Monaco S, Warchoł-Celińska E, Lorthioir A, Amar L, Aparicio LS, Beauloye C, Bruno RM, Chenu P, de Leeuw P, De Backer T, Delmotte P, Dika Z, Gordin D, Heuten H, Iwashima Y, Krzesinski JM, Kroon AA, Mazzolai L, Poch E, Sarafidis P, Seinturier C, Spiering W, Toubiana L, Van der Niepen P, van Twist D, Visonà A, Wautrecht JC, Witowicz H, Xu J, Prejbisz A, Januszewicz A, Azizi M, Persu A. European/International FMD Registry and Initiative (FEIRI), and the Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH). Cardiovascular Research - 2021. PMID: 32282921 - DOI: 10.1093/cvr/cvaa102        

Aldosterone synthase inhibitors for cardiovascular diseases: a comprehensive review of preclinical, clinical and in silico data. Lenzini L, Zanotti G, Bonchio M, Rossi GP. Pharmacological Research - 2021. PMID: 33271294 - DOI: 10.1016/j.phrs.2020.105332

Aldosterone and cortisol synthesis regulation by angiotensin-(1-7) and angiotensin-converting enzyme 2 in the human adrenal cortex. Caroccia B, Vanderriele PE, Seccia TM, Piazza M, Lenzini L, Prisco S, Torresan F, Domening O, Iacobone M, Poglitsch M, Rossi GP.J Hypertens. 2021 Mar 1. doi: 10.1097/HJH.0000000000002816. Online ahead of print.PMID: 33657582

The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism. Rossi GP, Bisogni V, Bacca AV, Belfiore A, Cesari M, Concistrè A, Del Pinto R, Fabris B, Fallo F, Fava C, Ferri C, Giacchetti G, Grassi G, Letizia C, Maccario M, Mallamaci F, Maiolino G, Manfellotto D, Minuz P, Monticone S, Morganti A, Muiesan ML, Mulatero P, Negro A, Parati G, Pengo MF, Petramala L, Pizzolo F, Rizzoni D, Rossitto G, Veglio F, Seccia TM.Int J Cardiol Hypertens. 2020 Apr 15;5:100029. doi: 10.1016/j.ijchy.2020.100029. eCollection 2020 Jun.PMID: 33447758

Familial hyperaldosteronism type 1 and pregnancy: successful treatment with low dose dexamethasone. Sanga V, Lenzini L, Seccia TM, Rossi GP.Blood Press. 2021 Jan 4:1-5. doi: 10.1080/08037051.2020.1863771. Online ahead of print.PMID: 33390031

Aldosterone synthase inhibitors for cardiovascular diseases: A comprehensive review of preclinical, clinical and in silico data. Lenzini L, Zanotti G, Bonchio M, Rossi GP.Pharmacol Res. 2021 Jan;163:105332. doi: 10.1016/j.phrs.2020.105332. Epub 2020 Dec 1.PMID: 33271294.

Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension. Rossi GP, Bisogni V, Rossitto G, Maiolino G, Cesari M, Zhu R, Seccia TM.High Blood Press Cardiovasc Prev. 2020 Dec;27(6):547-560. doi: 10.1007/s40292-020-00415-9. Epub 2020 Nov 7.PMID: 33159664

High Sodium Intake, Glomerular Hyperfiltration and Protein Catabolism in Patients with Essential Hypertension. Rossitto G, Maiolino G, Lerco S, Ceolotto G, Blackburn G, Mary S, Antonelli G, Berton C, Bisogni V, Cesari M, Seccia TM, Lenzini L, Pinato A, Montezano A, Touyz RM, Petrie MC, Daly R, Welsh P, Plebani M, Rossi GP, Delles C.Cardiovasc Res. 2020 Jul 16:cvaa205. doi: 10.1093/cvr/cvaa205. Online ahead of print.PMID: 33053160

Primary aldosteronism in elderly, old, and very old patients. Cesari M, Seccia TM, Maiolino G, Rossi GP.J Hum Hypertens. 2020 Dec;34(12):807-813. doi: 10.1038/s41371-020-00395-2. Epub 2020 Sep 14.PMID: 32929132

Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J.J Hypertens. 2020 Oct;38(10):1919-1928. doi: 10.1097/HJH.0000000000002510.PMID: 32890264

Resolution of drug-resistant hypertension by adrenal vein sampling-guided adrenalectomy: a proof-of-concept study. Torresan F, Rossitto G, Bisogni V, Lerco S, Maiolino G, Cesari M, Zhu R, Iacobone M, Seccia TM, Rossi GP.Clin Sci (Lond). 2020 Jun 12;134(11):1265-1278. doi: 10.1042/CS20200340.PMID: 32452518

Disease monitoring of Primary Aldosteronism. Rossi GP, Cesari M, Lenzini L, Seccia TM.Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101417. doi: 10.1016/j.beem.2020.101417. Epub 2020 Mar 10.PMID: 32336665.

Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J.J Hypertens. 2020 Oct;38(10):1919-1928. doi: 10.1097/HJH.0000000000002510.PMID: 32890264

Disease monitoring of Primary Aldosteronism. Rossi GP, Cesari M, Lenzini L, Seccia TM.Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101417. doi: 10.1016/j.beem.2020.101417. Epub 2020 Mar 10.PMID: 32336665.

Vitamin D supplementation: a novel therapy for aldosteronism? Rossi GP, Lenzini L.Nat Rev Endocrinol. 2020 Jun;16(6):303-304. doi: 10.1038/s41574-020-0359-3.PMID: 32286517.

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Rossi GP, Sanga V, Barton M.Elife. 2020 Apr 6;9:e57278. doi: 10.7554/eLife.57278.PMID: 32250244 

The cardiovascular consequences of hyperaldosteronism. Rossi GP, Seccia TM, Maiolino G, Cesari M.Ann Endocrinol (Paris). 2020 Feb 28:S0003-4266(20)30029-9. doi: 10.1016/j.ando.2020.02.006. Online ahead of print.PMID: 32192789

Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study. Rossi GP, Ceolotto G, Rossitto G, Maiolino G, Cesari M, Seccia TM.J Clin Endocrinol Metab. 2020 Jun 1;105(6):dgaa080. doi: 10.1210/clinem/dgaa080.PMID: 32067030

Atrial fibrillation as presenting sign of primary aldosteronism: results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study. Seccia TM, Letizia C, Muiesan ML, Lerco S, Cesari M, Bisogni V, Petramala L, Maiolino G, Volpin R, Rossi GP.J Hypertens. 2020 Feb;38(2):332-339. doi: 10.1097/HJH.0000000000002250.PMID: 31834121

Primary Aldosteronism: JACC State-of-the-Art Review. Rossi GP.J Am Coll Cardiol. 2019 Dec 3;74(22):2799-2811. doi: 10.1016/j.jacc.2019.09.057.PMID: 31779795.

Arterial Hypertension, Aldosterone, and Atrial Fibrillation. Seccia TM, Caroccia B, Maiolino G, Cesari M, Rossi GP.Curr Hypertens Rep. 2019 Nov 18;21(12):94. doi: 10.1007/s11906-019-1001-4.PMID: 31741119.

Heterogenous Responses to Cosyntropin in Primary Aldosteronism. Rossi GP.J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz133. doi: 10.1210/clinem/dgz133.PMID: 31665321 

Adrenal venous sampling in dye-allergic primary aldosteronism patients: prevalence, pitfalls and a possible solution. Battistel M, Ceolotto G, Barbiero G, Rossitto G, Rossi GP.J Hypertens. 2018 Sep;36(9):1942-1944. doi: 10.1097/HJH.0000000000001827.PMID: 30192309 

The Biology of Normal Zona Glomerulosa and Aldosterone-Producing Adenoma: Pathological Implications. Seccia TM, Caroccia B, Gomez-Sanchez EP, Gomez-Sanchez CE, Rossi GP.Endocr Rev. 2018 Dec 1;39(6):1029-1056. doi: 10.1210/er.2018-00060.PMID: 30007283 Review.

Does angiotensin II regulate parathyroid hormone secretion or not? Rossi GP, Prisco S.Clin Endocrinol (Oxf). 2018 Nov;89(5):568-569. doi: 10.1111/cen.13798. Epub 2018 Jul 11.PMID: 29947100 

Gitelman's Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations. Ravarotto V, Loffing J, Loffing-Cueni D, Heidemeyer M, Pagnin E, Calò LA, Rossi GP.Hypertens Res. 2018 Aug;41(8):578-588. doi: 10.1038/s41440-018-0061-1. Epub 2018 Jun 20.PMID: 29925901

Saga of Familial Hyperaldosteronism: Yet a New Channel. Lenzini L, Prisco S, Caroccia B, Rossi GP.Hypertension. 2018 Jun;71(6):1010-1014. doi: 10.1161/HYPERTENSIONAHA.118.11150. Epub 2018 May 7.PMID: 29735637 Review.

Mineralocorticoid receptor antagonists: time of repositioning them in the treatment of arterial hypertension. Rossi GP.J Hypertens. 2018 May;36(5):1015-1018. doi: 10.1097/HJH.0000000000001686.PMID: 29578956

Cure With Cryoablation of Arterial Hypertension Due to a Renin-Producing Tumor. Maiolino G, Battistel M, Barbiero G, Bisogni V, Rossi GP.Am J Hypertens. 2018 Apr 13;31(5):537-540. doi: 10.1093/ajh/hpx213.PMID: 29522074

Update in adrenal venous sampling for primary aldosteronism. Rossi GP.Curr Opin Endocrinol Diabetes Obes. 2018 Jun;25(3):160-171. doi: 10.1097/MED.0000000000000407.PMID: 29521660 Review.

Management of a Pregnant Woman With Fibromuscular Dysplasia. Berra E, Dominiczak AF, Touyz RM, Pierard S, Hammer F, Rossi GP, Micali RG, Staessen JA, Bursztyn M, Kahan T, Persu A.Hypertension. 2018 Apr;71(4):540-547. doi: 10.1161/HYPERTENSIONAHA.118.10819. Epub 2018 Feb 26.PMID: 29483231

Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term. Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Muiesan ML, Mannelli M, Negro A, Palumbo G, Parenti G, Rossi E, Mantero F; PAPY Study Investigators.Hypertension. 2018 Apr;71(4):585-591. doi: 10.1161/HYPERTENSIONAHA.117.10596. Epub 2018 Feb 26.PMID: 29483224

Effect of Continuous Positive Airway Pressure on Blood Pressure Variability in Patients With Obstructive Sleep Apnea. Pengo MF, Ratneswaran C, Berry M, Kent BD, Kohler M, Rossi GP, Steier J.J Clin Hypertens (Greenwich). 2016 Nov;18(11):1180-1184. doi: 10.1111/jch.12845. Epub 2016 Jun 1.PMID: 27251875

Adrenal vein sampling versus CT scanning in primary aldosteronism. Funder JW, Rossi GP.Lancet Diabetes Endocrinol. 2016 Nov;4(11):886. doi: 10.1016/S2213-8587(16)30240-6.PMID: 27793316

Recent advances in the diagnosis and management of obstructive sleep apnea. Vianello A, Bisogni V, Rinaldo C, Gallan F, Maiolino G, Braccioni F, Guarda-Nardini L, Molena B, Rossi GP, Marchese-Ragona R; Padova Sleep Apnea Study Group.Minerva Med. 2016 Dec;107(6):437-451. Epub 2016 Sep 13.PMID: 27625198 Review.

Estrogen Signaling in the Adrenal Cortex: Implications for Blood Pressure Sex Differences. Caroccia B, Seccia TM, Barton M, Rossi GP.Hypertension. 2016 Oct;68(4):840-8. doi: 10.1161/HYPERTENSIONAHA.116.07660.PMID: 27600178 Review.

Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism. Rossitto G, Miotto D, Battistel M, Barbiero G, Maiolino G, Bisogni V, Sanga V, Rossi GP.J Hypertens. 2016 Nov;34(11):2258-65. doi: 10.1097/HJH.0000000000001082.PMID: 27512976

Obituary: Cesare Dal Palù MD 20-01-1923-18-01-2016. Pessina AC, Rossi GP.J Hypertens. 2016 May;34(5):1022. doi: 10.1097/hjh.0000000000000900.PMID: 27482560

Endothelin-1 Drives Epithelial-Mesenchymal Transition in Hypertensive Nephroangiosclerosis. Seccia TM, Caroccia B, Gioco F, Piazza M, Buccella V, Guidolin D, Guerzoni E, Montini B, Petrelli L, Pagnin E, Ravarotto V, Belloni AS, Calò LA, Rossi GP.J Am Heart Assoc. 2016 Jul 21;5(7):e003888. doi: 10.1161/JAHA.116.003888.PMID: 27444511 

Randomised sham-controlled trial of transcutaneous electrical stimulation in obstructive sleep apnoea. Pengo MF, Xiao S, Ratneswaran C, Reed K, Shah N, Chen T, Douiri A, Hart N, Luo Y, Rafferty GF, Rossi GP, Williams A, Polkey MI, Moxham J, Steier J.Thorax. 2016 Oct;71(10):923-31. doi: 10.1136/thoraxjnl-2016-208691. Epub 2016 Jul 19.PMID: 27435610 Clinical Trial.

Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study. Cesari M, Letizia C, Angeli P, Sciomer S, Rosi S, Rossi GP.Circ Cardiovasc Imaging. 2016 Jun;9(6):e004815. doi: 10.1161/CIRCIMAGING.116.004815.PMID: 27307552

  Recent Dissertations

Cycle XXXII

Bisogni Valeria (held in Maastricht)

Piazza Maria (held in Maastricht)

Prisco Selene (held in Maastricht)

Torresan Francesca (held in Maastricht)


Cycle XXXIV

Caputo Ilaria

Nicolini Ettore

Presta Vivianne

Zhu Rui


Cycle XXXVI

Circosta Francesco

Giovanardi Francesco

Mariani Marco Valerio

Neccia Matteo

Petraglia Luca

Tini Melato Giacomo

  Contacts

Department of Medicine - DIMED
Via Giustiniani, 2 - 35128 Padova

Coordinator: Teresa Maria Seccia
teresamaria.seccia@unipd.it

Administrative Contacts
postlauream.dimed@unipd.it